(80 days)
Not Found
Not Found
No
The summary describes a simple sensor for measuring respiratory effort and contains no mention of AI, ML, or related concepts like image processing, training sets, or performance metrics typically associated with AI/ML devices.
No
The device is an "indicator of respiratory effort for recording onto a data acquisition system," which describes a diagnostic or monitoring function, not a therapeutic intervention.
No
The device is described as an "indicator of respiratory effort for recording onto a data acquisition system," implying it measures a physiological parameter. However, the "Intended Use / Indications for Use" does not state that it is used to diagnose a disease, condition, or for screening purposes with diagnostic intent. It merely records data, which might later be used in a diagnostic process by a clinician, but the device itself isn't performing the diagnosis.
No
The device description explicitly mentions "Ultima Respiratory Effort Sensor, 0520 and 0522," which are likely hardware components, indicating it is not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "An indicator of respiratory effort for recording onto a data acquisition system." This describes a device that measures a physiological parameter (respiratory effort) directly from the patient's body, not a test performed on a sample taken from the body.
- Device Description: The description "Ultima Respiratory Effort Sensor" further supports this. Sensors typically interact directly with the patient.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), which is a defining characteristic of IVD devices.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device measures a physical parameter of the patient directly.
N/A
Intended Use / Indications for Use
An indicator of respiratory effort for recording onto a data acquisition system.
Product codes
73 BZQ
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Children and adult patients
Intended User / Care Setting
Sleep disorder screenings occur at a sleep laboratory.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.2375 Breathing frequency monitor.
(a)
Identification. A breathing (ventilatory) frequency monitor is a device intended to measure or monitor a patient's respiratory rate. The device may provide an audible or visible alarm when the respiratory rate, averaged over time, is outside operator settable alarm limits. This device does not include the apnea monitor classified in § 868.2377.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle are three stylized human profiles facing to the right, with flowing lines above them that could represent hair or movement.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEB I I 1998
Richard A. Bonato, Ph.D. Braebon Medical Corporation P.O. Box 72094 Kanata, ON, K2K 2P4 CANADA
Re: K982216 Ultima Respiratory Effort Sensor Models 0520 and 0522 Requlatory Class: II (two) Product Code: 73 BZQ Dated: June 15, 1998 Received: June 23, 1998
Dear Dr. Bonato:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
1
Page 2 - Richard A. Bonato, Ph.D.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diaqnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use Statement
K9%2216__(To be assigned) 510 (k) Number__
| Device Name: | Ultima Respiratory Effort Sensor, 0520 and 0522 |
|---|---|
| Indications for Use: | An indicator of respiratory effort for recording onto a data acquisition |
| system. | |
| Target Population: | Children and adult patients who are screened during sleep disorder |
| studies | |
| Environment of Use: | Sleep disorder screenings occur at a sleep laboratory. |
Concurrence of CDRH, Office of Device Evaluation (ODE)
name
Prescription Use_ V
OR Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________ (Per 21 CFR 801.109)